GARDEN BIO-CHEM(SZ:300401) Xin Lang Cai Jing·2026-02-09 05:22Group 1 - Garden Biologics experienced a decline of 5.22% on February 9, with a stock price of 18.15 yuan per share and a trading volume of 585 million yuan, resulting in a turnover rate of 5.88% and a total market capitalization of 9.864 billion yuan [1] - The company, Zhejiang Garden Biologics Co., Ltd., was established on December 18, 2000, and went public on October 9, 2014. Its main business focuses on developing, producing, and selling products related to a complete vitamin D3 industry chain [1] - The revenue composition of the company includes vitamin products at 47.41%, pharmaceuticals at 30.22%, lanolin and its derivatives at 20.93%, sales of raw materials and others at 1.01%, rental income at 0.31%, other trade products at 0.10%, and medical devices at 0.01% [1] Group 2 - Among the top circulating shareholders of Garden Biologics, a fund under Southern Fund holds a position. The Southern CSI 1000 ETF (512100) reduced its holdings by 48,400 shares in the third quarter, now holding 3.4785 million shares, which accounts for 0.65% of the circulating shares [2] - The estimated floating loss for the Southern CSI 1000 ETF (512100) today is approximately 3.4785 million yuan. The fund was established on September 29, 2016, with a latest scale of 78.996 billion yuan, and has achieved a 6% return this year, ranking 1533 out of 5580 in its category [2] - The fund manager, Cui Lei, has a tenure of 7 years and 96 days, with a total fund asset size of 137.02 billion yuan. The best fund return during the tenure is 279.97%, while the worst return is -15.93% [2]